Free delivery nationwide for orders above ₱800

 
RXDRUG-DRP-10683-1pc

SAPHCLAZIDE-60 Gliclazide 60mg Modified-Release Tablet 1's

Selling for 1150
1300
You save: 1.50
Out of stock
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Description

Indications

Diabetes mellitus, type 2
 

Administration

Should be taken with food.
 

Contraindications

Hypersensitivity to gliclazide, other sulfonylureas or sulfonamides. Type 1 diabetes mellitus, diabetic coma and pre-coma, diabetic ketoacidosis. Severe hepatic or renal impairment. Pregnancy and lactation. Concomitant use with miconazole.
 

Special Precautions

Patient with risk factors for hypoglycaemia (e.g. malnourished, severe or poorly compensated endocrine disorders, severe vascular disease), G6PD-deficiency, porphyria, stress-related states (e.g. severe trauma, fever, infection, surgery). Mild to moderate hepatic or renal impairment. Elderly.
 

Storage

Store between 15-30°C.
 

MedsGo Class

Antidiabetic Agents

Features

Brand
Saphclazide-60
Full Details
Dosage Strength
60 mg
Drug Ingredients
  • Gliclazide
Drug Packaging
Modified-Release Tablet 1's
Generic Name
Gliclazide
Dosage Form
Modified-Release Tablet
Registration Number
DRP-10683
Drug Classification
Prescription Drug (RX)
Find similar